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Surgical or Endovascular Options for Patients With
Acute Limb Ischemia? The Hybrid Procedures May
Increase Clinical Outcomes
Gianmarco de Donato, Francesco Setacci, Pasqualino
Sirignano, Giuseppe Galzerano, Rosaria Massaroni,
Alessandro Cappelli, Carlo Setacci. Department of
Medicine, Surgery and Neuroscience, Vascular and
Endovascular Surgery Unit, Siena, Italy
Objectives: Surgical arterial thromboembolectomy (TE)
is an efﬁcient treatment for acute arterial emboli of lower limbs,
especially if a single large artery is involved. Unfortunately,
residual thrombus, propagation of thrombi, chronic athero-
sclerotic disease and vessel injuries secondary to
balloon catheter passage may limit the clinical success rate.
Intraoperative angiography can identify any arterial imper-
fection after TE, which may be corrected simultaneously by
endovascular techniques (so called“hybridprocedures” -HP).
The aim of this study is to compare outcomes of surgical
TE vs HP in patients with acute limb ischemia (ALI).
Methods: From 2006 to 2012, 322 patients with ALI
were admitted in our Department. Patients received urgent
surgical treatment using only Fogarty’s balloon catheter
(FTE group ¼ 112) or in conjunction with endovascular
completion (HP group ¼ 210) on the basis of the
surgeon’s favorite practices and run-off vessel patency.
In-hospital complications, 30-day mortality, primary
and secondary patency, reintervention rate and limb salvage
at 24 months were compared in the 2 groups.
Results: Hybrid procedures (n ¼ 210) following
surgical TE consisted in angioplasty (PTA) 6 stenting in
98 cases, intraluminal thrombo-aspiration + PTA 6 stent-
ing in 47, ﬁbrinolyisis + PTA 6 stenting in 38, ﬁbrinolyisis
+ intraluminal thrombo-aspiration + PTA 6 stenting in 27.
Mortality rate at 6 months was 7.4% (8% in the FTE group,
and 7.1% in the HP group; P ¼ ns). Primary patency and
freedom from reintervention rates at 24 months were
superior in the HP group compared to the FTE group,
respectively 80.5% vs 62.5% (P < .02), and 90.5% vs
64.3% (P < .02).
Estimated limb salvage at 24 months was 86.6 % in the
HP group vs 74.5% in the FTE group (P ¼ .3).
Conclusions: Hybrid procedures for ALI may consti-
tute the armamentarium of therapeutic strategies that,
when applied to speciﬁc clinical scenarios, hold the poten-
tial to reduce the morbidity and mortality previously asso-
ciated with acute arterial occlusion.
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Prevalence and Predictor of In-Stent Occlusion After
Endovascular Treatment With Nitinol Stents for
Femoropopliteal Lesion: Insight From Retrospective
Multicenter Analysis for Femoropopliteal Lesion
RegistryTomoharu Dohi1, Osamu Iida1, Yoshimitsu Soga2,
Mitsuyoshi Takahara3, Masaaki Uematsu1. 1Kansai Rosai
Hospital, Amagasaki, Japan; 2Kokura Memorial Hospital,
Kitakyusyu, Japan; 3Osaka University, Suita, Japan
Objectives: The purpose of this study is to investigate
the prevalence and predictors of in-stent occlusion.
Methods: This study is a retrospective analysis of
a multi-center database. Between January 2004 and
December 2011, 2447 lesions from 1954 patients with
FP lesions (mean age, 73.0 6 9.3 years; 71% male) were
treated with nitinol stents. Multivariate analysis for clinical
and procedural predictors of in-stent occlusion was per-
formed with Cox proportional hazard ratio.
Results: Sixty-one percent of the patients had diabetes
and 71% were claudicant. Mean lesion length was 142 6
88 mm and 52% were chronic total occlusions (CTOs).
Mean follow-up period was 2.36 1.7 years. In-stent occlu-
sion rate was 5.2%, 11.2%, and 16.4% at 1, 3, and 5 years,
respectively. Multivariate analysis revealed female gender
(hazard ratio [HR], 1.64; P ¼ .0009), critical limb
ischemia (HR, 1.48; P ¼ .017), cilostazol administration
(HR, 0.53; P < .0001), TASC II class C/D lesions (HR,
2.05; P ¼ .0015), CTOs (HR, 1.46; P ¼ .0425), lesion
length > 200 mm (HR, 1.60; P ¼ .0127), reference vessel
diameter < 6 mm (HR, 1.37; P ¼ .0427) to be indepen-
dent predictors of in-stent occlusion after FP stenting.
Conclusions: The rate of in-stent occlusion was lower
thanexpected andFPstenting appears tobe a viable treatment
option. Better patient selection and use of adjunctive medical
therapy may further improve the outcome of FP stenting.
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18 F-FDG-PET CT Scan: Future Gold Standard in
Diagnosis of Vascular Graft Infection?
Raghvinder P. Gambhir, Pritee Padgaonkar, Varinder Bedi,
Surinder Singh. Vascular Surgery, Army Hospital, Delhi,
India
Objectives: To evaluate the utility of 18 F-FDG PET
CT in the diagnosis of Abdominal and Peripheral vascular
graft infections.
Methods: All patients with suspected graft infection in
a study period of 18 months were included in the study.
Detailed history, clinical examination along with complete
cell count, CRP, ESR, blood cultures were obtained. All
underwent CT Angiography and FDG-PET CT. Protocol
used was: whole body PET/CT Scan (base of skull
to mid thigh) 45 minutes after intravenous injection of
18F-FDG @ 0.15 Mci/Kg body weight. Images were
reconstructed and reformatted 3 D image & fusion images
of PET & CT were also obtained to give accurate anatom-
ical correlation. SUV max values indicated a positive
report/ infectious event. Microbiological cultures were ob-
tained from explanted grafts and tissue aspirates.
Results: Twelve patients with suspected graft infection
were included in the study. Male to female ration was 11:1;
median age was 56 years (43-70 years). Time interval
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from 6 weeks to 12 years. Presentation included discharg-
ing sinus, Pseudo aneurysm, or non-speciﬁc symptoms like
erythema, fever and pain. Nine patients showed increased
18F-FDG uptake within the graft and in surrounding soft
tissue, 2 showed increased up take in surrounding soft
tissue alone and in one patient no uptake was seen within
the graft/soft tissue. FDG PET CT had a sensitivity of
100%, Speciﬁcity of 66.6%, a Positive predictive value of
87.5% and a Negative predictive value of 100%. Klebsiella,
pseudomonas, E coli and Morganella Morgagni were the
common organisms isolated.
Conclusions: 18F-FDG PET/CT is a reliable non-
invasive imaging modality for the diagnosis of vascular
graft-related infection. The precise anatomic localization
of increased 18F-FDG uptake provided by PET/CT
enables accurate differentiation between graft and soft-
tissue infection. It is the future Gold Standard test.
Author Disclosures: V. Bedi: Nothing to disclose; R. P.
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One-Year Results of the Multilayer Flow Modulator
Stent in the Management of Thoracoabdominal
Aortic Aneurysms
Sherif Sultan1, Niamh Hynes2. 1Vascular & Endovascular
Surgery, Western Vascular Institute, Galway, Ireland;
2Galway Clinic, Galway, Ireland
Objectives: We report early results using multi-layer
ﬂow modulator (MFM) stent technology for aortic repair.
Methods: Out of 243 cases implanted worldwide we
present the ﬁrst 55 cases that were implanted under indica-
tion for use. All were done on compassionate basis, in 11
countries.
Primary Endpoints are Freedom from Rupture and
Aneurysm-related Death.
Results: They were 31 Thoraco-abdominal (8 Type I,
3 Type II, 9 Type III, and 11 Type IV), 7 arch, 3 abdom-
inal and 8 suprarenal aneurysms and 6 type B dissections.
Mean age of 64.5 years; mean aneurysm diameter was
6.04cm+/1.66cm and mean length was 11.58cm+/
7.62cm. The mean number of side branches covered
was 3.7 per case for a total number of 202branches.
Mean stents per case was 1.96.
Aneurysm related survival 93.7% (SE+/4.44%) at one
year. No rupture occurred. Four cases of consumptive coa-
gulopathy were observed, two of which resulted in death
from hemorrhagic cerebrovascular stroke and one of which
resulted in death from a gastrointestinal bleed.
Technical success was 98.2%. One-year all-cause
survival was 84.8% (SE+/6.25%). There was no para-
plegia No peri-operative visceral or renal insult occurred.
At 12 months all of the 202 side branches were patent.
There were no stent fractures.
One-year intervention free survival was 92.4% (SE+/
5.09%) At six months the mean rate of sac volume
increase was 0.36% per month, resulting in a mean volume
increase of 2.14%. At twelve months the rate of increase
had slowed to 0.28% per month, resulting in a total average
increase in sac volume of 3.26%. The ratio of thrombus tototal volume stayed almost constant over the 12 months at
0.48, while the ratio of ﬂow to total volume fell from 0.21
to 0.12 at 12 months.
Conclusions: Increasing sac size did not herald
rupture. MFM implantation instigates a process of aortic
remodeling involving initial thrombus deposition, which
slowed between six and twelve months. The MFM was
not associated with loss of native side branches.
Author Disclosures: N. Hynes: Nothing to disclose; S.
Sultan: Nothing to disclose.IF8.
Endovascular Treatment of Abdominal Aortic
Aneurysms Should Not Be Denied to High-Surgical-
Risk Patients
Celio T. Mendonca1, Claudio A. Carvalho2, Janaina
Weingartner1, Alexandre Y. Shiomi2, Daniel S. Costa2,
Cristiano M. Schmitt2. 1Red Cross University Hospital.
Positivo University, Curitiba, Brazil; 2VITA Curitiba
Hospital, Curitiba, Brazil
Objectives: To analyze the initial and long-term
results of endovascular aneurysm repair (EVAR) in high-
surgical-risk patients (i.e., age $ 80 years, serum creatinine
level $ 3 mg/dL, severe pulmonary dysfunction, severe
cardiac dysfunction) with favorable anatomy (ie, proximal
neck length of at least 15mm, proximal neck angulation
< 60, absence of thrombus in the proximal neck).
Methods: From April 2002 to November 2012, 80
consecutive high-surgical-risk patients (65 men; mean age
74 years, range 54-91 years) with an abdominal aortic
aneurysm (AAA; mean diameter 66.6 mm) who were
treated electively using a bifurcated aortic endograft (39
Excluder, 40 Zenith, 1 Endurant) were entered in
a prospective registry. Fifty-ﬁve (68.7%) patients were
classiﬁed ASA III and 25 (31.3%) were ASA IV. High-
surgical-risk status was corroborated using the validated
Customized Probability Index score. All patients used sta-
tins and betablockers in the perioperative period. Primary
end points were operative mortality and long-term survival;
secondary end points were the frequency of reintervention,
evolution of the aneurysm sac, rates of primary and
secondary patency and rupture.
Results: ThemeanCustomized Probability Index score
in our patients was 12.1. Operative mortality was 1.25% (1/
80). There were 5 endoleaks and 2 endograft limb occlu-
sions. Four patients required reintervention during the
mean follow-up of 35.9 months. Survival at 3 years was
91.25%. Primary and secondary patency rates at 3 years
were 97.5% and 100%, respectively. There were no ruptures.
Conclusions: Our initial and long-term results with
EVAR in high-risk patients were satisfactory and appear
to justify this approach in this patient population. The
most important factor for improvement of the short and
long-term results of aortic endografts is respect of anatomic
feasibility conditions.
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